AbVision
Business Services · Nevada, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1575 Delucchi Ln, Reno, Nevada, 89502, U...Phone Number
(408) 493-1822Website
www.abvisioninc.comRevenue
<$5 MillionIndustry
About AbVision
AbVision, Inc. is a biopharmaceutical company based in the San Francisco Bay Area, specializing in the discovery and development of therapeutic antibodies, vaccines, and cell therapies. The company utilizes innovative technology platforms, such as SpeedyAb and ImmunoBuster, to create next-generation bio-therapeutics aimed at treating cancer and infectious diseases. AbVision's product pipeline includes advanced candidates like the anti-CD47 therapeutic antibody AVI-105 and a novel COVID-19 vaccine candidate, AVI-205, both available for out-licensing and collaborations. Their target clients include pharmaceutical companies and research institutions seeking to develop and commercialize cutting-edge therapies.Explore more
SIC Code 87,873NAICS Code 54,541Show moreAbVision Org Chart
Compare Similar Companies to AbVision
Compare insights from companies similar to AbVision, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
AbVision Tech Stack
A closer look at the technologies used by AbVision
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding AbVision
Sign Up For FreeTo access detailed company insights
AbVision, Inc. is a biopharmaceutical company based in the San Francisco Bay Area, specializing in the discovery and development of therapeutic antibodies, vaccines, and cell therapies. The company utilizes innovative technology platforms, such as SpeedyAb and ImmunoBuster, to create next-generation bio-therapeutics aimed at treating cancer and inf... Read More